Zhejiang Conba Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Zhejiang Conba Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Zhejiang Conba Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Productive biological assets17,198,0369.6E-4382015-06-30historic
Net change in cash1,713,018,4980.0952702015-06-30historic
Goodwill1,132,641,8170.06295742015-06-30historic
Selling expenses701,962,9050.03901792015-06-30historic
Cash paid for other financing activities693,428,4490.03854802015-06-30historic
Comprehensive income attributable to minority shareholders53,230,1230.00296962015-06-30historic
Minority interests gain53,230,1230.00296972015-06-30historic
Disposal of fixed assets and others20,202,5700.001121042015-06-30historic
Cash from minority shareholders of subsidiaries11,958,9216.6E-41202015-06-30historic
Net income493,034,4560.02741352015-06-30historic
Operating profit571,448,4360.031761402015-06-30historic
Net cashflow from financing activities1,610,163,4520.089491452015-06-30historic
Total profit589,931,4670.032791462015-06-30historic
Total comprehensive income493,034,4560.02741582015-06-30historic
Other payables826,912,7860.045962002015-06-30historic
Cash paid for taxes411,126,1340.022852182015-06-30historic
Interest receivable4,074,4872.3E-42432015-06-30historic
Investment income from associate and joint venture3,897,0792.2E-42482015-06-30historic
Construction materials76,1100.02622015-06-30historic
Net cash and cash equivalents ending balance2,365,287,6370.131452662015-06-30historic
Notes receivable341,798,5680.0192892015-06-30historic
Cash inflows from financing activities3,079,572,0780.171153062015-06-30historic
Intangible assets644,423,5630.035813102015-06-30historic
Minority interest424,130,4740.023573212015-06-30historic
Proceeds from sell of investment186,722,1720.010383252015-06-30historic
Non-operating loss4,416,8522.5E-43352015-06-30historic
Cash from other investing activities9,430,6855.2E-43502015-06-30historic
Long term accounts payable871,2545.0E-53652015-06-30historic
Long term equity investment191,755,1540.010663872015-06-30historic
Short term borrowings1,388,942,0880.077194272015-06-30historic
Financial expenses55,742,3930.00314442015-06-30historic
Deferred tax assets64,700,8010.00364502015-06-30historic
Long term borrowings325,754,2000.01814512015-06-30historic
Total non-current assets4,335,688,5040.240965252015-06-30historic
Cash paid for dividends, profits or interests145,683,8020.00815312015-06-30historic
Total liabilities4,511,571,3740.250735432015-06-30historic
Interests payable2,952,7211.6E-45532015-06-30historic
Net cash flows from investing activities-117,945,128-0.006555722015-06-30historic
Prepayment167,739,4770.009325862015-06-30historic
Total liabilities and equity9,518,772,8030.529016052015-06-30historic
Refunds of taxes3,348,2941.9E-46222015-06-30historic
Fixed assets1,563,653,6630.08696232015-06-30historic
Revenue2,211,388,5610.12296322015-06-30historic
Purchases of fixed assets and others129,509,9230.00726332015-06-30historic
Cash inflows from operating activities2,248,141,0820.124946372015-06-30historic
Capital reserve1,751,596,8070.097356552015-06-30historic
Accounts payable571,317,1320.031756572015-06-30historic
Cash outflows from operating activities2,027,262,2320.112676672015-06-30historic
Total cost of goods sold1,804,196,6680.100276832015-06-30historic
Inventories843,496,5050.046887082015-06-30historic
Other receivables64,417,6160.003587252015-06-30historic
Payroll payable29,507,6070.001647542015-06-30historic
Other current assets23,492,1310.001318282015-06-30historic